News Releases
- Chugai Received Second Rating in Pharmaceutical Sector in the “DJSI World,” a Global ESG Investment Index
- Galderma’s Announcement Regarding Nemolizumab (CHMP Positive Opinion for the Treatment of Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis)
- Galderma’s Announcement Regarding NEMLUVIO (FDA Approval for the Treatment of Moderate to Severe Atopic Dermatitis)
Science and Technology
Science and Technology
Careers at Chugai
Careers at Chugai
Videos
CPR celebrates 10th Anniversary